Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sustained angiogenesis, through either local sprouting (angiogenesis) or the recruitment of bone marrow-derived cells (BMDCs) (vasculogenesis), is essential to the development of a tumor. How BMDCs are recruited to the tumor and their contribution to the tumor vasculature is poorly understood. Here, we demonstrate that both IL-8 and angiogenin contribute to the complementary pathways of angiogenesis and BMDC mobilization to increase tumor growth. These two factors are regulated by PHD2 in a HIF-independent but NF-kappaB-dependent manner. PHD2 levels are decreased in human cancers, compared with corresponding normal tissue, and correlate with an increase in mature blood vessels. Thus, PHD2 plays a critical role in regulating tumor angiogenesis.

Original publication

DOI

10.1016/j.ccr.2009.04.010

Type

Journal article

Journal

Cancer Cell

Publication Date

02/06/2009

Volume

15

Pages

527 - 538

Keywords

Animals, Basic Helix-Loop-Helix Transcription Factors, Bone Marrow Cells, Cells, Cultured, Endothelial Cells, Endothelium, Vascular, Humans, Hypoxia-Inducible Factor 1, alpha Subunit, Hypoxia-Inducible Factor-Proline Dioxygenases, Interleukin-8, Male, Mice, Mice, SCID, NF-kappa B, Neoplasm Transplantation, Neoplasms, Experimental, Neovascularization, Pathologic, Procollagen-Proline Dioxygenase, Ribonuclease, Pancreatic